Acne Medication Market to Surge at 5.49% CAGR, which is anticipated to reach USD 14.68 billion by 2030.

CRI Report has released a report titled “Acne Medication market – Analysis of Market Size, Share & Trends for 2020 – 2030 and Forecasts to 2030” which is anticipated to reach USD 14.68 billion by 2030. According to this Report, the market is anticipated to portray a CAGR of 5.49% between 2020 and 2030. According to the report, Acne medication market expansion is being fueled by an increase in the global occurrence of acne diseases. Teenagers’ adoption of unhealthy lifestyles and growing acceptance of skincare products are two major reasons driving market growth. The availability and emergence of a wide range of products containing antibiotic agents, such as lotions, creams, and gels, as well as the additional advantages associated with their usage, would boost demand for acne medication.

The market report on Acne Medication market includes in-depth insights as:

• The estimated value of the market was USD 8.6 billion in the year 2020.
• Region-wise, the market in North America which held the largest market share in the year 2020, emerged as a key market for Acne Medication market.
• Based on Formulation, Topical category emerged as a key segment in the Acne Medication market.
• Based on Product, Retinoids segment emerged as a key segment in the Acne Medication market.
• Key players are likely to focus on product innovations and expansion through mergers to retain their positions in developed markets.

“The industry will grow in the coming years due to rising awareness of therapeutics in acne treatment and the increasing incidence of acne disorders in the many regions due to climate change. However, as a result of continuous advancements, increased knowledge of acne medication choices such as dermo-cosmetics, biologics, and complementary and alternative medicines (CAM) has boosted product acceptance across the globe. Several CAM therapies have been marketed as acne treatments as a result of research and development activities, and are generally considered safe.”, according to this report

Acne vulgaris, often known as acne, is a common skin condition that occurs when the hair follicles get clogged as a result of excessive oil production, debris, and dead skin cells. Pimples, whiteheads, blackheads, and scars may accompany it. Inflammatory and non-inflammatory acne are the two forms of acne that exist. Acne therapy involves utilizing drugs and medications to remove dead skin cells, reduce sebum output, and eliminate germs.

Acne Medication market is segmented by Formulation into Topical and Oral. Among these, the Topical category is expected to hold the highest CAGR in the forecast period. This is because retinoids, BPO, azelaic acid, antibiotics, and salicylic acid are used topically for acne maintenance and mild to severe acne.

Key Players in the Market

• Some of the key players operating in the Acne Medication market are Allergan Plc, GlaxoSmithKline Plc, Johnson Johnson, Mayne Pharma Group Limited, Mylan N V, Nestle S A, Pfizer Inc, Sun Pharma, Teva Pharmaceutical Industry Ltd, Valeant Pharmaceutical International.

Get Valuable Insights into Acne Medication market

In the new report, CRI Report thrives to present an unbiased analysis of the Acne Medication market that covers the historical demand data as well as the forecast figures for the period, i.e., 2020-2030. The study includes compelling insights into growth that is witnessed in the market. The market is segmented by Formulation into Topical, Oral. By Product into Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid, Others. By Type into Prescription, OTC. By Acne Type into Inflammatory Acne, Non-Inflammatory Acne. By Distribution Channel into Retail Stores, Pharmacies & Drug Stores, E-commerce. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East, and Africa.

Related Post

https://www.cri-report.com/industry/healthcare/acne-drugs-market-to-surge-at-12-76-cagr-which-is-anticipated-to-reach-usd-6-89-billion-by-2030/